2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic

Jeffrey A Towbin1, William J McKenna2, Dominic J Abrams3

  • 1Le Bonheur Children's Hospital, Memphis, Tennessee; University of Tennessee Health Science Center, Memphis, Tennessee.

Heart Rhythm
|May 13, 2019
PubMed

Insights

Arrhythmogenic cardiomyopathy (ACM) is a complex heart muscle disorder with diverse causes, including genetic and inflammatory conditions. This consensus provides clinical guidance on evaluating and managing ACM, focusing on exercise recommendations for arrhythmogenic right ventricular cardiomyopathy.

Area of Science:

  • Cardiology
  • Genetics
  • Pathology

Background:

  • Arrhythmogenic cardiomyopathy (ACM) encompasses a range of myocardial disorders not caused by ischemia, hypertension, or valvular disease.
  • It includes conditions like arrhythmogenic right/left ventricular cardiomyopathy, cardiac amyloidosis, sarcoidosis, Chagas disease, and left ventricular noncompaction.
  • ACM shares overlapping phenotypes with other cardiomyopathies, notably dilated cardiomyopathy presenting with arrhythmias.

Purpose of the Study:

  • To provide clinicians with expert guidance on the evaluation and management of arrhythmogenic cardiomyopathy (ACM).
  • To offer clinically relevant information on the genetics and disease mechanisms underlying ACM.
  • To develop evidence-based recommendations for exercise in arrhythmogenic right ventricular cardiomyopathy using PICO questions.

Main Methods:

  • Utilized PICO (Population, Intervention, Comparison, Outcome) questions to assess contemporary evidence.
  • Conducted a systematic literature search with evidence tables.
  • Developed recommendations based on expert consensus, literature review, and clinical experience, using the ACC/AHA Class of Recommendation and Level of Evidence system.

Main Results:

  • Recommendations for ACM evaluation and management were developed.
  • Specific guidance on exercise in arrhythmogenic right ventricular cardiomyopathy was formulated.
  • The consensus statement integrates genetic insights and disease mechanisms.

Conclusions:

  • ACM is a heterogeneous group of disorders requiring comprehensive evaluation and management strategies.
  • Understanding the genetic basis of ACM is crucial for elucidating disease triggers and pathways.
  • This expert consensus provides a framework for evidence-based clinical practice in ACM.

Related Concept Videos

Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
332
SI Units: 2019 Redefinition01:13

SI Units: 2019 Redefinition

Measurement is an indispensable part of analytical chemistry. The result of measurement helps quantify a substance's physical property and compare it with the physical property of another substance. Each measurement comprises two components - a number indicating the magnitude and a unit of measurement as a standard for comparison. Further, the same quantity can be measured using different units of measurement, which leads to differences in magnitude.
A standard set of units has been defined...
3.4K
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
307
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
509
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
451
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
496